• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND ARCHITECT AFP; ALPHA-FETOPROTEIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND ARCHITECT AFP; ALPHA-FETOPROTEIN Back to Search Results
Catalog Number 03P36-25
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
All available patient information was included.Additional patient details are not available.An evaluation is in process.A final report will be submitted when the evaluation is complete.
 
Event Description
The customer observed discrepant alpha 1 fetoprotein (afp) results on the architect analyzer.The following data provided: initial 14, repeats 10, 20 for a patient between the ages of 1 and 3 years old.There was no impact to patient management reported.
 
Manufacturer Narrative
On march 19, 2019 additional patient details were provided.The child was diagnosed clinically with isolated mammoplasia.This was noted on clinical examination when the child presented with urinary tract infection at the age of 4 months.Sex hormones, hcg, tfts and general biochemistry were all normal (the child was 2 years old when seen last in opd).The expected result was expected to be normal in view of the above.An evaluation is still in process, a follow up report will be provided when the evaluation is completed.
 
Manufacturer Narrative
Further investigation of the customer issue included a review of the complaint text, a search for similar complaints, review of field data, and a review of labeling.No adverse trend was identified for the customer's issue.No return patient sample was available.Historical performance of the reagent lot was evaluated using world wide data.The patient data was analyzed and within established control limits.Labeling was reviewed and found to be adequate.Based on all available information and abbott diagnostics' complaint investigation no product deficiency was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT AFP
Type of Device
ALPHA-FETOPROTEIN
Manufacturer (Section D)
ABBOTT IRELAND
diagnostics division
finisklin business park
sligo NA
EI  NA
MDR Report Key8348266
MDR Text Key139794130
Report Number3008344661-2019-00016
Device Sequence Number1
Product Code LOK
UDI-Device Identifier00380740081317
UDI-Public00380740081317
Combination Product (y/n)N
PMA/PMN Number
P120008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup,Followup
Report Date 05/03/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/29/2019
Device Catalogue Number03P36-25
Device Lot Number91429FN00
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 01/25/2019
Initial Date FDA Received02/18/2019
Supplement Dates Manufacturer Received03/19/2019
05/01/2019
Supplement Dates FDA Received04/09/2019
05/03/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR ANALYZER; ARCHITECT I2000SR ANALYZER; ARCHITECT I2000SR ANALYZER; LN 03M74-97 SN ISR01419; LN 03M74-97 SN ISR01419; LN 03M74-97 SN ISR01419
Patient Age2 YR
-
-